In May 2022 the Canadian Centre for Ethics in Sport (CCES) has reported an anti-doping rule violation against the field hockey player Audrey Sawers after her sample tested positive for the prohibited substance Canrenone.
After notification the Athlete gave a prompt admission, waived her right for a hearing, accepted a provisional suspension and the sanction proposed by CCES.
The prohibited substance was consumed by the Athlete in a prescription medication for which a therapeutic use exemption (TUE) had not yet been granted by the CCES. The CCES has since granted the athlete a TUE for use of Canrenone.
Therefore CCES decides on 28 September 2022 to impose a 1 month period of ineligibility on the Athlete, starting on 8 September 2022.
